"Peptidyl-Dipeptidase A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. It is a Cl(-)-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. It may also have endopeptidase activity on some substrates. (From Enzyme Nomenclature, 1992)
| Descriptor ID |
D007703
|
| MeSH Number(s) |
D08.811.277.656.350.350.687
|
| Concept/Terms |
Peptidyl-Dipeptidase A- Peptidyl-Dipeptidase A
- Peptidyl Dipeptidase A
- Angiotensin I-Converting Enzyme
- Angiotensin I Converting Enzyme
- Carboxycathepsin
- CD143 Antigens
- Kininase II
- Dipeptidyl Peptidase A
- Antigens, CD143
- Angiotensin Converting Enzyme
- Kininase A
|
Below are MeSH descriptors whose meaning is more general than "Peptidyl-Dipeptidase A".
Below are MeSH descriptors whose meaning is more specific than "Peptidyl-Dipeptidase A".
This graph shows the total number of publications written about "Peptidyl-Dipeptidase A" by people in this website by year, and whether "Peptidyl-Dipeptidase A" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 6 | 1 | 7 |
| 1993 | 5 | 6 | 11 |
| 1994 | 5 | 8 | 13 |
| 1995 | 6 | 8 | 14 |
| 1996 | 8 | 6 | 14 |
| 1997 | 13 | 7 | 20 |
| 1998 | 17 | 6 | 23 |
| 1999 | 15 | 7 | 22 |
| 2000 | 15 | 4 | 19 |
| 2001 | 11 | 8 | 19 |
| 2002 | 44 | 29 | 73 |
| 2003 | 46 | 36 | 82 |
| 2004 | 68 | 50 | 118 |
| 2005 | 46 | 53 | 99 |
| 2006 | 68 | 39 | 107 |
| 2007 | 67 | 34 | 101 |
| 2008 | 95 | 34 | 129 |
| 2009 | 73 | 26 | 99 |
| 2010 | 100 | 24 | 124 |
| 2011 | 66 | 38 | 104 |
| 2012 | 75 | 27 | 102 |
| 2013 | 87 | 35 | 122 |
| 2014 | 66 | 29 | 95 |
| 2015 | 47 | 33 | 80 |
| 2016 | 67 | 16 | 83 |
| 2017 | 40 | 24 | 64 |
| 2018 | 48 | 23 | 71 |
| 2019 | 16 | 12 | 28 |
| 2020 | 410 | 507 | 917 |
| 2021 | 35 | 72 | 107 |
To return to the timeline, click here.
Below are the most recent publications written about "Peptidyl-Dipeptidase A" by people in Profiles.
-
Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021; 16(9):e0257016.
-
COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis. BMC Infect Dis. 2021 Sep 03; 21(1):901.
-
The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department. Medicina (Kaunas). 2021 Aug 20; 57(8).
-
"Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry. Int J Mol Sci. 2021 Aug 20; 22(16).
-
Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells. J Transl Med. 2021 08 19; 19(1):358.
-
HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain. 2021 Aug 12; 22(1):94.
-
A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus. Front Cell Infect Microbiol. 2021; 11:707194.
-
SARS-CoV-2 infection and ACE2 inhibition. J Hypertens. 2021 08 01; 39(8):1555-1558.
-
An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria. Redox Biol. 2021 10; 46:102078.
-
Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach. Comput Biol Med. 2021 08; 135:104654.